"We want (clinical trial registration) to be mandatory to make sure drug companies aren't hiding anything," she said.
Under current rules, drug makers are able to withhold from the public unfavorable studies of drugs in the regulatory pipeline - such as a study showing that the drug doesn't work against a particular disease.
No comments:
Post a Comment